|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
35,410,000 |
Market
Cap: |
13.66(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$206.89 - $413.31 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 463 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Medpace Holdings is a holding company. Through its subsidiaries, Co. is a clinical contract research organization focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Co. provides a suite of services supporting the clinical development process from Phase I to Phase IV across a range of therapeutic areas. Co.'s services include medical department, clinical trial management, study start-up, patient recruitment and retention, clinical monitoring, risk-based monitoring, regulatory affairs, medical writing, biometrics and data sciences, pharmacovigilance, and quality assurance.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
2,000,000 |
Total Buy Value |
$0 |
$0 |
$0 |
$309,116,534 |
Total People Bought |
0 |
0 |
0 |
2 |
Total Buy Transactions |
0 |
0 |
0 |
34 |
Total Shares Sold |
775,132 |
1,954,537 |
3,671,939 |
3,760,365 |
Total Sell Value |
$315,716,326 |
$777,957,532 |
$1,216,956,934 |
$1,236,631,446 |
Total People Sold |
5 |
6 |
8 |
8 |
Total Sell Transactions |
29 |
58 |
97 |
104 |
End Date |
2024-03-02 |
2023-11-30 |
2023-06-01 |
2022-06-01 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Medpace Investors, Llc |
10% Owner |
|
2021-04-15 |
4 |
AS |
$186.65 |
$5,836,546 |
D/D |
(31,270) |
6,422,212 |
|
-3% |
|
Geiger Jesse J |
CFO & COO, Lab Operations |
|
2021-04-14 |
4 |
S |
$180.00 |
$540,000 |
D/D |
(3,000) |
6,382 |
|
-1% |
|
Geiger Jesse J |
CFO & COO, Lab Operations |
|
2021-04-14 |
4 |
OE |
$28.32 |
$84,960 |
D/D |
3,000 |
9,382 |
|
- |
|
Ewald Stephen P |
General Counsel & Corp. Secy. |
|
2021-04-14 |
4 |
S |
$180.67 |
$216,804 |
D/D |
(1,200) |
13,854 |
|
-1% |
|
Ewald Stephen P |
General Counsel & Corp. Secy. |
|
2021-04-14 |
4 |
OE |
$28.32 |
$33,984 |
D/D |
1,200 |
15,054 |
|
- |
|
Troendle August J. |
President & CEO |
|
2021-04-14 |
4 |
AS |
$180.48 |
$671,386 |
I/I |
(3,720) |
6,453,482 |
|
1% |
|
Medpace Investors, Llc |
10% Owner |
|
2021-04-14 |
4 |
AS |
$180.48 |
$671,386 |
D/D |
(3,720) |
6,453,482 |
|
1% |
|
Burwig Susan E |
Exec. VP, Operations |
|
2021-03-03 |
4 |
S |
$167.00 |
$1,037,237 |
D/D |
(6,211) |
70,005 |
|
-12% |
|
Geiger Jesse J |
CFO & COO, Lab Operations |
|
2021-02-10 |
4 |
S |
$160.00 |
$640,000 |
D/D |
(4,000) |
6,382 |
|
-10% |
|
Geiger Jesse J |
CFO & COO, Lab Operations |
|
2021-02-10 |
4 |
OE |
$23.00 |
$92,000 |
D/D |
4,000 |
10,382 |
|
- |
|
Ewald Stephen P |
General Counsel & Corp. Secy. |
|
2021-02-09 |
4 |
S |
$155.48 |
$1,554,800 |
D/D |
(10,000) |
13,854 |
|
-16% |
|
Ewald Stephen P |
General Counsel & Corp. Secy. |
|
2021-02-09 |
4 |
OE |
$90.65 |
$906,500 |
D/D |
10,000 |
23,854 |
|
- |
|
Troendle August J. |
President & CEO |
|
2021-01-08 |
4 |
AS |
$140.71 |
$3,752,173 |
I/I |
(26,666) |
6,457,202 |
|
16% |
|
Medpace Investors, Llc |
10% Owner |
|
2021-01-08 |
4 |
AS |
$140.71 |
$3,752,173 |
D/D |
(26,666) |
6,457,202 |
|
16% |
|
Medpace Investors, Llc |
10% Owner |
|
2021-01-07 |
4 |
AS |
$140.06 |
$13,102,893 |
D/D |
(93,552) |
6,483,868 |
|
16% |
|
Troendle August J. |
President & CEO |
|
2021-01-07 |
4 |
AS |
$140.06 |
$13,102,893 |
I/I |
(93,552) |
6,483,868 |
|
16% |
|
Medpace Investors, Llc |
10% Owner |
|
2021-01-06 |
4 |
AS |
$140.06 |
$12,838,880 |
D/D |
(91,667) |
6,577,420 |
|
16% |
|
Troendle August J. |
President & CEO |
|
2021-01-06 |
4 |
AS |
$140.06 |
$12,838,880 |
I/I |
(91,667) |
6,577,420 |
|
16% |
|
Troendle August J. |
President & CEO |
|
2021-01-06 |
4 |
OE |
$14.41 |
$2,857,085 |
I/I |
185,347 |
6,669,087 |
|
- |
|
Medpace Investors, Llc |
10% Owner |
|
2021-01-06 |
4 |
OE |
$14.41 |
$2,857,085 |
D/D |
185,347 |
6,669,087 |
|
- |
|
Troendle August J. |
President & CEO |
|
2021-01-04 |
4 |
AS |
$140.01 |
$1,417,881 |
I/I |
(10,127) |
6,483,740 |
|
19% |
|
Medpace Investors, Llc |
10% Owner |
|
2021-01-04 |
4 |
AS |
$140.01 |
$1,417,881 |
D/D |
(10,127) |
6,483,740 |
|
19% |
|
Troendle August J. |
President & CEO |
|
2020-12-30 |
4 |
AS |
$140.01 |
$2,790,399 |
I/I |
(19,930) |
6,493,867 |
|
15% |
|
Medpace Investors, Llc |
10% Owner |
|
2020-12-30 |
4 |
AS |
$140.01 |
$2,790,399 |
D/D |
(19,930) |
6,493,867 |
|
15% |
|
Medpace Investors, Llc |
10% Owner |
|
2020-12-28 |
4 |
AS |
$140.00 |
$192,360 |
D/D |
(1,374) |
6,513,797 |
|
20% |
|
247 Records found
|
|
Page 9 of 10 |
|
|